Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
Price Target
Average
133.28%
Revenue Forecast
Estimate
53.99%
EBIT
Estimate
--18.89%
Net Income
Estimate
36.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Apellis Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for APLS of $69.8 , with forecasts ranging from
a
low of
$39 to a high of $96 .
APLS Lowest Price Target
Wall Street Target
39 USD
30.28%
APLS Average Price Target
Wall Street Target
69.8 USD
133.28%
APLS Highest Price Target
Wall Street Target
96 USD
220.69%
REVENUE FORECAST
Revenue Forecast Chart APLS
EBIT FORECAST
EBIT Forecast Chart APLS
NET INCOME FORECAST
Net Income Chart APLS